Aquagenic pruritus, explained properly

The definition, and why it is so precise

Aquagenic pruritus is a chronic neurosensory skin condition: intense itching, prickling, stinging, tingling or burning triggered by contact with water of essentially any temperature, salinity or source. Tap water, rain, seawater, swimming pools, sweat and high humidity all appear as triggers.

The diagnostic hallmark is the complete absence of primary skin lesions during an episode — no wheals, no hives, no flare. That single criterion is what separates it from aquagenic urticaria, and it matters, because the two conditions respond to completely different treatments.

Confusingly, the name of this site is not the medical term. Aquaprurigo is the older, informal French-language name; clinicians and journals say aquagenic pruritus. Strictly, 'prurigo' refers to conditions where scratching produces papules or nodules, which is a different family altogether.

Timing: two distinct patterns

The temporal signature is stereotyped enough to be diagnostically useful. In roughly half of people, symptoms begin within seconds to minutes of water contact. In the other half, they begin 2 to 15 minutes after exposure has completely stopped — a delay that reliably obscures the cause.

Individual episodes generally run 10 to 120 minutes, averaging about 40.6 minutes across published series. In one polycythaemia vera cohort the distribution was more compressed: 26.2% started within a minute, 33.3% within one to five minutes, and 40.5% after more than five; 61.9% had short episodes of one to ten minutes, and just over half had them daily.

Water temperature does not behave the way most people expect. In that same cohort, hot water aggravated the itch in 57.1% of cases against only 1.9% for cold — which is the opposite of the common assumption, and the opposite of some individual experiences. Temperature response appears genuinely variable between people.

Distribution: symmetrical, with characteristic sparing

Affected sites are highly symmetrical and concentrate on the thighs, upper arms, forearms, shins, chest, back and abdomen. Palms, soles, head, neck and mucosal surfaces are characteristically spared. That sparing pattern is worth mentioning to a clinician, because it is unusual and it is specific.

Whether the abdomen is involved carries particular weight. Among patients whose aquagenic itch was not associated with a blood disorder, 82.4% reported no abdominal itching at all; among those with a myeloproliferative neoplasm, only 17.6% did. It is one of the four items in the self-check.

The burden, which is routinely underestimated

Because nothing is visible, the impact tends to be discounted by everyone except the person experiencing it. Published cohorts report sleep disruption, anxiety, clinical depression, systematic water avoidance and, in some cases, ablutophobia — a genuine fear of bathing. Roughly a third of sufferers in one series avoided water contact, and those with higher itch-intensity scores avoided it significantly more.

The absence of visible marks does not mean the sensation is mild. It means the evidence is inside the nervous system rather than on the surface.

How common it is

These are not comparable samples, and none of them is a global prevalence figure. The spread does, however, point at environmental contributors — water composition, climate, bathing habits — alongside genetic predisposition. Mean age at onset is around 25, and familial clustering suggests an inherited predisposition in some cases.

Mechanism: why histamine is the wrong target

The failure of high-dose, non-sedating antihistamines is the central clue. It points to a dominantly non-histaminergic itch pathway, and current thinking implicates several interacting mechanisms:

• MrgprD-expressing sensory neurons. Reduced steady-state activity in these epidermal neurons, with diminished glutamatergic tone, appears to remove a normal inhibitory brake on dermal mast cells and neighbouring nerve fibres.
• Acetylcholine around sweat glands. Biopsies show increased acetylcholinesterase activity in eccrine-associated nerve fibres after water exposure, implying local acetylcholine release acting as a direct pruritogen — and a feedback loop in which sweating sustains the signal.
• Cutaneous fibrinolytic activity. Classic work found raised fibrinolytic activity before and after water contact, blockable with ε-aminocaproic acid, implicating plasminogen activators and protease signalling through PAR-2 on nerve terminals.
• Mast cell and basophil behaviour. Degranulation and raised blood histamine occur, but as part of the cascade rather than as the whole story — which is why blocking the histamine receptor alone changes little.

This model has a directly testable consequence, and it is the one interesting therapeutic lead in the field: β-alanine is an MrgprD agonist, and taking it before water contact appears to reduce the itch — presumably by pre-activating and then desensitising the very fibres that water would otherwise excite. More on that.

Primary and secondary

The reason the distinction matters so much: the itch can arrive first. That is what makes a baseline blood count worth having rather than optional. What to ask for.

How it is investigated

1. History. Trigger, latency after water contact, duration, distribution, whether the abdomen is involved, whether spontaneous episodes occur, and the effect on washing behaviour.
2. Examination during or just after an episode, specifically to confirm there are no primary lesions. This is what separates it from aquagenic urticaria, and it is easy to get wrong from memory alone.
3. A water challenge where the diagnosis is unclear — applying water at controlled temperatures and observing. Wheals mean urticaria; itch without wheals supports aquagenic pruritus.
4. Blood work. A full blood count as the baseline. If counts are abnormal, or the pattern is suggestive, JAK2 V617F mutation testing and serum erythropoietin follow.
5. Review of the alternatives — xerosis, cholinergic urticaria, atopic eczema, and systemic causes of chronic itch including thyroid, liver and kidney disease.